Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayada R Bani

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Breast (Edinburgh, Scotland)|April 4, 2009
Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patientsFolkward G Wiesner, Achim Magener, Peter A Fasching, et al.
Anticancer Research|February 11, 2014
Health utilities in gynecological oncology and mastology in GermanyThomas Hildebrandt, Falk C Thiel, Peter A Fasching, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 12, 2009
Neurokinin 1 receptor gene polymorphism might be correlated with recurrence rates in endometriosisStefan P Renner, Arif B Ekici, Christian Maihöfner, et al.
Archives of Gynecology and Obstetrics|February 6, 2014
Comprehensive visualization of paresthesia in breast cancer survivorsSebastian M Jud, Reinhard Hatko, Christian Maihöfner, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|October 9, 2013
Assessment of breast volume changes during human pregnancy using a three-dimensional surface assessment technique in the prospective CGATE studyChristian M Bayer, Mayada R Bani, Michael Schneider, et al.
Aesthetic Plastic Surgery|April 14, 2011
Breast volumetry using a three-dimensional surface assessment techniqueMartin C Koch, Boris Adamietz, Sebastian M Jud, et al.
Breast Cancer Research and Treatment|December 1, 2007
Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patientsPeter Andreas Fasching, Christian R Loehberg, Pamela L Strissel, et al.
BMC Cancer|October 31, 2018
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancerPaul Gass, Michael P Lux, Claudia Rauh, et al.
Breast Cancer Research and Treatment|August 31, 2012
Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physiciansFalk C Thiel, Michael G Schrauder, Peter A Fasching, et al.
Archives of Gynecology and Obstetrics|October 20, 2012
Financing of certified centers: a willingness-to-pay analysisFalk C Thiel, Anton Scharl, Thomas Hildebrandt, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Breast (Edinburgh, Scotland)|April 4, 2009
Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patientsFolkward G Wiesner, Achim Magener, Peter A Fasching, et al.
Anticancer Research|February 11, 2014
Health utilities in gynecological oncology and mastology in GermanyThomas Hildebrandt, Falk C Thiel, Peter A Fasching, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 12, 2009
Neurokinin 1 receptor gene polymorphism might be correlated with recurrence rates in endometriosisStefan P Renner, Arif B Ekici, Christian Maihöfner, et al.
Archives of Gynecology and Obstetrics|February 6, 2014
Comprehensive visualization of paresthesia in breast cancer survivorsSebastian M Jud, Reinhard Hatko, Christian Maihöfner, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|October 9, 2013
Assessment of breast volume changes during human pregnancy using a three-dimensional surface assessment technique in the prospective CGATE studyChristian M Bayer, Mayada R Bani, Michael Schneider, et al.
Aesthetic Plastic Surgery|April 14, 2011
Breast volumetry using a three-dimensional surface assessment techniqueMartin C Koch, Boris Adamietz, Sebastian M Jud, et al.
Breast Cancer Research and Treatment|December 1, 2007
Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patientsPeter Andreas Fasching, Christian R Loehberg, Pamela L Strissel, et al.
BMC Cancer|October 31, 2018
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancerPaul Gass, Michael P Lux, Claudia Rauh, et al.
Breast Cancer Research and Treatment|August 31, 2012
Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physiciansFalk C Thiel, Michael G Schrauder, Peter A Fasching, et al.
Archives of Gynecology and Obstetrics|October 20, 2012
Financing of certified centers: a willingness-to-pay analysisFalk C Thiel, Anton Scharl, Thomas Hildebrandt, et al.
Pageof 3